Determination of Telmisartan in Human Plasma by LC-MS/MS and Bioequivalence Study of It

WANG Guo-cai,ZHANG Dan,YANG Man,ZHENG Tian-lei,WANG Tao,WANG Zhen-long,HAN Jing,LIU Hui-chen

2011-01-01

Abstract:OBJECTIVE:To establish LC-MS/MS method for the determination of telmisartan in human plasma and to investigate the bioequivalence of 2 kinds of Telmisartan preparations.METHODS:After protein precipitation with acetonitrile,the determination was performed on Zorbax SB-C_(18)Narrow Bore column with the mobile phase consisted of methanol-10 mmol·L~(-1)ammonium acetate(containing 0.5% formic acid)(80∶20)at a flow rate of 0.4 mL·min~(-1).Detection was carried out by API3200 electrospray positive ionization mass spectrometry in the multiple reaction monitoring(MRM)mode.The MRM transitions of m/z 515.2→276.2 and m/z 748.5→158.2 were used to quantify telmisartan and clarithromycin(internal standard),respectively.RESULTS:Telmisartan and clarithromycin were eluted at 1.51 min and 1.25 min,respectively.The calibration curve was linear over the concentration range of 1.00～1 500 ng·mL~(-1)(r=0.998 5)with the lowest detection limit of 1.00 ng·mL~(-1).Intra-day RSD and inter-day RSD were both less than 6%,and the RE were within ±7%.The mean extract recovery was(93.0±3.9)%.Main pharmacokinetic parameters of test preparation and reference preparation were as follows:t_(1/2)(25.5±12.5)h and(26.5±11.8)h,t_(max)(1.50±0.78)h and(1.59±1.16)h,c_(max)(358±212)ng·mL~(-1)and(389±298)ng·mL~(-1),AUC_(0～96h)(2 383±1 146)ng·h·mL~(-1)and(2 411±1 192)ng·h·mL~(-1).The average bioavailability of telmisartan(test preparation)is(101.3±22.6)%.CONCLUSION:The method is effective,sensitive and specific,and the 2 kinds of tablets are bioequivalent.